{
  "Category": "Global or ExUS Equities - Industry Sector",
  "Asset Type": "Equities (Stocks)",
  "Tags": "-",
  "Return% 1Y": "-1.29%",
  "Total Holdings": "27",
  "Perf Week": "-1.60%",
  "Sponsor": "Van Eck Associates Corporation",
  "ETF Type": "",
  "Return% 3Y": "5.36%",
  "AUM": "347.10M",
  "Perf Month": "1.58%",
  "Fund Family": "",
  "Bond Type": "",
  "Return% 5Y": "1.07%",
  "NAV/sh": "",
  "Perf Quarter": "8.39%",
  "Index": "MVIS US Listed Biotech 25 Index",
  "Average Maturity": "",
  "Return% 10Y": "",
  "52W High": "178.95 -3.84%",
  "Perf Half Y": "22.40%",
  "Index Weighting": "",
  "Commodity Type": "",
  "Return% SI": "",
  "52W Low": "135.34 27.15%",
  "Perf YTD": "9.63%",
  "Active/Passive": "",
  "Quant Type": "",
  "Flows% 1M": "-4.28%",
  "Volatility": "1.07% 1.11%",
  "Perf Year": "-1.29%",
  "Dividend TTM": "1.25 (0.73%)",
  "ESG Type": "",
  "Flows% 3M": "-5.99%",
  "ATR (14)": "2.12",
  "Perf 3Y": "15.92%",
  "Dividend Ex-Date": "Dec 23, 2024",
  "Dividend Type": "",
  "Sector/Theme": "",
  "Flows% YTD": "-19.02%",
  "RSI (14)": "57.43",
  "Perf 5Y": "3.96%",
  "Dividend Gr. 3/5Y": "46.65% 21.54%",
  "Structure Type": "",
  "Region": "",
  "Flows% 1Y": "",
  "Beta": "0.78",
  "Perf 10Y": "45.12%",
  "Expense": "0.35%",
  "Growth/Value": "",
  "SMA20": "2.02%",
  "Flows% 3Y": "",
  "Rel Volume": "0.82",
  "Prev Close": "174.69",
  "Inverse/Leveraged": "",
  "Market Cap": "",
  "SMA50": "3.45%",
  "Flows% 5Y": "",
  "Avg Volume": "6.40K",
  "Price": "172.08",
  "IPO": "Dec 21, 2011",
  "Option/Short": "Yes / Yes",
  "SMA200": "8.40%",
  "Trades": "",
  "Volume": "5,224",
  "Change": "-1.49%",
  "Dividends": []
}